ALDACTAZIDE

This brand name is authorized in Turkey, United States

Active ingredients

The drug ALDACTAZIDE contains a combination of these active pharmaceutical ingredients (APIs):

1 Spironolactone UNII 27O7W4T232 - SPIRONOLACTONE

Spironolactone, as a competitive aldosterone antagonist, increases sodium excretion whilst reducing potassium loss at the distal renal tubule. It has a gradual and prolonged action. Read about Spironolactone

2 Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE

Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. Read about Hydrochlorothiazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C03EA01	Hydrochlorothiazide and potassium-sparing agents	C Cardiovascular system → C03 Diuretics → C03E Diuretics and potassium-sparing agents in combination → C03EA Low-ceiling diuretics and potassium-sparing agents
Discover more medicines within C03EA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699543010014, 8699543010168
Country: US	FDA, National Drug Code	Identifier(s): 0025-1011, 0025-1021